Sybrava 284mg/1.5 ml Pre-Filled Syringe 1s

Sybrava 284mg/1.5 ml Pre-Filled Syringe is a prescription-only injectable medicine containing Inclisiran, a small interfering RNA (siRNA)-based therapy. It is designed to act at the molecular level within liver cells to regulate the production of specific proteins involved in lipid metabolism.

Inclisiran works by selectively silencing the messenger RNA responsible for the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). By reducing PCSK9 levels, it enhances the liver’s natural ability to remove low-density lipoprotein (LDL) particles from the bloodstream. This targeted mechanism allows for sustained therapeutic effects with infrequent dosing.

Due to its long-acting nature and novel mechanism, ongoing monitoring and adherence to scheduled dosing are essential components of therapy.

Administration

This medication is administered as a subcutaneous injection (under the skin). It should be given by a qualified healthcare professional or under medical supervision, unless otherwise instructed.

• Common injection sites include the abdomen, upper arm, or thigh
• Injection sites should be rotated to minimize local irritation
• The pre-filled syringe is single-use and should not be reused
• Allow the syringe to reach room temperature before administration if taken from refrigeration
• Avoid injecting into areas with skin irritation, bruising, or infection

Dosage & Treatment Schedule

The standard dosing regimen involves an initial dose, followed by a second dose at 3 months, and subsequent maintenance doses every 6 months thereafter. This extended dosing interval is made possible by the prolonged activity of Inclisiran at the genetic level.

Dosage adjustments are generally not required in most patients; however, all dosing decisions should be made by a healthcare provider based on individual clinical assessment.

Shelf Life

Sybrava pre-filled syringes typically have a shelf life of up to 24 months when stored under recommended conditions. Always check the expiry date on the packaging prior to administration and do not use expired product.

Storage Instructions

• Store in a refrigerator at 2°C to 8°C
• Do not freeze, as freezing may compromise stability
• Keep the syringe in its original carton to protect from light
• If necessary, it may be kept at room temperature (below 25°C) for a limited duration
• Avoid exposure to excessive heat, humidity, or direct sunlight
• Keep out of reach of children and pets
• Dispose of used syringes in an approved sharps container

Composition

The formulation also contains inactive excipients that support stability and delivery. Refer to the official product leaflet for the complete list, especially if you have known sensitivities.

Side Effects

As with any injectable therapy, some individuals may experience side effects. These are generally mild to moderate and often resolve without intervention.

Common:

• Injection site reactions (pain, redness, swelling, or rash)
• Joint pain (arthralgia)
• Mild respiratory symptoms such as bronchitis
• Urinary tract infections
• Fatigue

Less Common:

• Skin hypersensitivity reactions
• Localized rash or itching
• Mild elevation in liver enzymes

Serious (Require Immediate Attention):

• Severe allergic reactions (facial swelling, breathing difficulty)
• Persistent or worsening systemic symptoms

Contraindications

• Known hypersensitivity to Inclisiran or any formulation components
• Pregnancy or breastfeeding unless clearly advised by a healthcare professional
• Severe hepatic impairment without medical supervision
• Use in paediatric populations unless prescribed by a specialist

Drug Interactions

Inclisiran has a low potential for drug-drug interactions due to its mechanism of action and metabolic pathway.

• No significant interactions with statins or other lipid-modifying therapies
• Minimal involvement with cytochrome P450 enzyme systems
• Always inform your healthcare provider about all medications and supplements

Food & Lifestyle Considerations

• No specific dietary restrictions are required
• A balanced, heart-conscious diet is recommended
• Regular physical activity supports overall outcomes
• Moderate alcohol intake is advisable

Monitoring & Precautions

• Periodic lipid profile monitoring is recommended
• Liver function may be assessed in certain patients
• Adherence to scheduled dosing is critical for sustained effect
• Report any unusual or persistent symptoms promptly

Quick Tips

• Follow the prescribed dosing timeline strictly
• Do not skip scheduled injections
• Inspect the solution before administration
• Ensure proper refrigerated storage at all times
• Do not shake the syringe
• Do not share medication with others
• Maintain regular follow-up appointments